Literature DB >> 15825399

Studies on the mechanism of action of miconazole: effect of miconazole on respiration and cell permeability of Candida albicans.

K H Sreedhara Swamy, M Sirsi, G R Ramananda Rao.   

Abstract

The antifungal drug, miconazole nitrate, inhibits the growth of several species of Candida. Candida albicans, one of the pathogenic species, was totally inhibited at a concentration of approximately 10 mug/ml. Endogenous respiration was unaffected by the drug at a concentration as high as 100 mug/ml, whereas exogenous respiration was markedly sensitive and inhibited to an extent of 85%. The permeability of the cell membrane was changed as evidenced by the leakage of 260-nm absorbing materials, amino acids, proteins, and inorganic cations. The results we present clearly show that the drug alters the cellular permeability, and thus the exogenous respiration becomes sensitive to the drug.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 15825399      PMCID: PMC428986          DOI: 10.1128/AAC.5.4.420

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  Damage by streptomycin to the cell membrane of Escherichia coli.

Authors:  N ANAND; B D DAVIS
Journal:  Nature       Date:  1960-01-02       Impact factor: 49.962

2.  A modified ninhydrin colorimetric analysis for amino acids.

Authors:  H ROSEN
Journal:  Arch Biochem Biophys       Date:  1957-03       Impact factor: 4.013

3.  The absorption of polymyxin E by bacteria and bacterial cell walls and its bactericidal action.

Authors:  A V FEW; J H SCHULMAN
Journal:  J Gen Microbiol       Date:  1953-12

4.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

5.  The adsorption of cetyltrimethylammonium bromide by bacteria, its action in releasing cellular constituents and its bactericidal effects.

Authors:  M R J SALTON
Journal:  J Gen Microbiol       Date:  1951-05

6.  Mode of action of azalomycin F. Effect of azalomycin F on Candida albicans.

Authors:  S Sugawara
Journal:  J Antibiot (Tokyo)       Date:  1967-03       Impact factor: 2.649

7.  Miconazole nitrate in the topical treatment of dermatomycoses. A clinical evaluation.

Authors:  R Vandaele; K Uyttendaele
Journal:  Arzneimittelforschung       Date:  1972-07

8.  Miconazole, a new broad-spectrum antimycotic, in the treatment of vaginal candidosis.

Authors:  M Thiery; B J Mrozowski; H Van Kets
Journal:  Mykosen       Date:  1972-01-01

9.  Studies on the mode of action of the phenolic antibacterial agent fentichlor against Staphylococcus aureus and Escherichia coli. II. The effects of fentichlor on the bacterial membrane and the cytoplasmic constituents of the cell.

Authors:  W B Hugo; S F Bloomfield
Journal:  J Appl Bacteriol       Date:  1971-09

10.  Mode of action of lomofungin.

Authors:  D Gottlieb; G Nicolas
Journal:  Appl Microbiol       Date:  1969-07
View more
  37 in total

1.  Scanning electron microscopy of Candida albicans after in vitro treatment with miconazole.

Authors:  S De Nollin; M Borgers
Journal:  Antimicrob Agents Chemother       Date:  1975-05       Impact factor: 5.191

2.  The effects of miconazole on the ultrastructure of Candida albicans.

Authors:  S De Nollin; M Borgers; H Van Belle
Journal:  Proc R Soc Med       Date:  1977

3.  Miconazole induces fungistasis and increases killing of Candida albicans subjected to photodynamic therapy.

Authors:  Sara B Snell; Thomas H Foster; Constantine G Haidaris
Journal:  Photochem Photobiol       Date:  2011-12-20       Impact factor: 3.421

4.  Miconazole: a review of its antifungal activity and therapeutic efficacy.

Authors:  P R Sawyer; R N Brogden; R M Pinder; T M Speight; G S Avery
Journal:  Drugs       Date:  1975       Impact factor: 9.546

5.  Antagonistic action of lipid components of membranes from Candida albicans and various other lipids on two imidazole antimycotics, clotrimazole and miconazole.

Authors:  H Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  1977-07       Impact factor: 5.191

6.  Intravenous and intrathecal miconazole therapy for systemic mycoses.

Authors:  J P Sung; J G Grendahl; H B Levine
Journal:  West J Med       Date:  1977-01

7.  Growth phase in relation to ketoconazole and miconazole susceptibilities of Candida albicans.

Authors:  W H Beggs
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

8.  Miconazole and amphotericin B alter polymorphonuclear leukocyte functions and membrane fluidity in similar fashions.

Authors:  K Yasui; M Masuda; T Matsuoka; M Yamazaki; A Komiyama; T Akabane; K Murata
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

9.  Mechanisms of azole resistance in petite mutants of Candida glabrata.

Authors:  Sophie Brun; Thierry Bergès; Pascal Poupard; Carole Vauzelle-Moreau; Gilles Renier; Dominique Chabasse; Jean-Philippe Bouchara
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

10.  Synergistic effects of miconazole and polymyxin B on microbial pathogens.

Authors:  Silvia Pietschmann; Katrin Hoffmann; Michael Voget; Ulrich Pison
Journal:  Vet Res Commun       Date:  2008-12-16       Impact factor: 2.459

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.